Brokerage Reports
Tonix Pharmaceuticals Holding Corp. [TNXP]
Reports for Purchase
Showing records 21 - 40 ( 154 total )
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Price: 25.00
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Price: 10.00
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
2Q18 Recap - Data Presentation (August) Could Explain Pathway
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Price: 25.00
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Price: 25.00
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Price: 10.00
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Price: 10.00
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Preview of Interim Analysis for HONOR Study - Multiple Positive Scenarios
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Price: 10.00
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Price: 10.00
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
1Q18 Recap - Interim PTSD Look Coming This Summer
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Price: 25.00
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Price: 25.00
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
4Q17 Recap - Interim PTSD Look on Track for 3Q18
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Price: 25.00
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Price: 25.00
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
3Q17 Recap - Interim PTSD Look on Track for 1H18
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Price: 25.00
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
News expected on Tonmya Phase 3 trial in 2018
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Price: 25.00